Aura Biosciences (NASDAQ:AURA – Get Free Report) released its quarterly earnings data on Tuesday. Aura Biosciences Trading Up 1.0%Shares of NASDAQ:AURA traded up $0.08 on Tuesday, hitting $7.78. The stock’s 50 day moving average price is $6.94 and its 200 day moving average price is $6.69. Aura Biosciences Company Profile(Get Free Report)Aura Biosciences is a clinical‐stage biopharmaceutical company focused on the development of novel virus‐like particle (VLP) therapies for the treatment of cancer. See AlsoReceive News & Ratings for Aura Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aura Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.